v3.26.1
Segments (Tables)
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule of Financial Data for the Company’s Reportable Segment

The following table presents specific financial data for the Company’s reportable segment (in thousands):

 

(Dollar amounts in thousands)  2026   2025   2026   2025 
   Three months ended June 30,   Six months ended June 30, 
(Dollar amounts in thousands)  2026   2025   2026   2025 
Operating expenses:                    
Research & development expenses-clinical asset development  $185   $222   $447   $411 
Research & development expense – related parties   117    1,638    633    2,365 
                     
General and administrative expenses – legal & professional fees   300    872    1,013    1,632 
General and administrative expenses – accounting & audit fees   639    378    1,348    922 
General and administrative expenses – salaries, payroll and stock based compensation   470    751    1,013    1,444 
General and administrative expenses - other   1,291    1,091    2,204    1,794 
Total operating costs and expenses   3,002    4,952    6,658    8,568 
Operating loss   (3,002)   (4,952)   (6,658)   (8,568)
Other income (expenses):                    
Other expense   (1,536)   (1,023)   (1,826)   (1,992)
Loss on investment   (86)   -    (154)   - 
Interest income   -    4    -    12 
Interest expense, net   (17)   (57)   (66)   (233)
Total other (expense) income, net   (1,639)   (1,076)   (2,046)   (2,213)
Net loss  $(4,641)  $(6,028)  $(8,704)  $(10,781)